Guam Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 24, 2026

an hour ago

Nature Translational Psychiatry Study Reveals Distinct Functional Neuronal Signatures in Patient-Derived Brain Organoids with Itay&Beyond’s Neurotech Platform

GlobeNewswire

2 hours ago

ONERugged Vehicle-Mounted Computer V82T Launches to Transform Fleet Management

GlobeNewswire

2 hours ago

Connecting the World, Driving Apex Growth: Apexmind Summit 2026 Successfully Held in HongKong

GlobeNewswire

2 hours ago

Micro, AMFI and CEiiA Join Forces to create the next generation microcars and industrialize BEN in Turin

GlobeNewswire

3 hours ago

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

GlobeNewswire

3 hours ago

SUSE Advances Intelligent Infrastructure Management with Latest AI and Virtualization Updates

GlobeNewswire

3 hours ago

Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis

GlobeNewswire

4 hours ago

Press release: Availability of the Q1 2026 aide-mémoire

GlobeNewswire

4 hours ago

Communiqué de presse : Mise en ligne du document «Q1 2026 aide-mémoire »

GlobeNewswire

4 hours ago

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

GlobeNewswire

4 hours ago

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

GlobeNewswire

4 hours ago

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé au Japon comme premier médicament ciblé pour le traitement des adultes atteints de pemphigoïde bulleuse

GlobeNewswire

4 hours ago

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

GlobeNewswire

5 hours ago

Accumulus Technologies Launches the Accumulus Connector, Delivering Live Integration Across Regulatory Systems

GlobeNewswire

5 hours ago

Accumulus Technologies stellt den Accumulus Connector vor – Live-Integration über regulatorische Systeme hinweg

GlobeNewswire

5 hours ago

anynines advances Klutch to power a9s Hub for Kubernetes data service orchestration across on-premises and AWS environments

GlobeNewswire

5 hours ago

Accumulus Technologies lance Accumulus Connector, afin d’offrir une intégration en temps réel avec les systèmes réglementaires

GlobeNewswire

5 hours ago

アキュミュラステクノロジーズ、規制システム間のリアルタイム統合を実現するアキュミュラスコネクターを発表

GlobeNewswire

6 hours ago

Nghiên cứu lâm sàng cung cấp bằng chứng cho việc sử dụng Lacprodan® IF-3070 của Arla Foods Ingredients trong sữa công thức dành cho trẻ sơ sinh

GlobeNewswire

6 hours ago

Studi Klinis Menunjukkan Bukti untuk Penggunaan Lacprodan® IF-3070 dari Arla Foods Ingredients dalam Susu Formula Bayi

GlobeNewswire